Procyon Corp - Understand $pcyn stock

$PCYN Market Cap: $1.632 Million

Research Board Inbox Deep Research Not Interested Shortlisted

Financial Snapshot

Revenue

$4.984M

TTM

Gross Margin

78.07%

TTM

Net Earnings

-$341.1K

TTM

Current Assets

$2.366M

Q2 2024

Current Liabilities

$769.2K

Q2 2024

Current Ratio

307.56%

Q2 2024

Total Assets

$3.204M

Q2 2024

Total Liabilities

$917.1K

Q2 2024

Book Value

$2.287M

Q2 2024

Cash

$326.1K

Q2 2024

P/E

-4.784

Nov 22, 2024 EST

Free Cash Flow

-$125.2K

TTM

Revenues

Revenue YoY Change

Revenues

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue	$4.984M	$4.687M	$4.842M	$4.720M	$4.334M	$4.191M	$4.020M	$4.012M	$3.449M	$2.772M	$2.840M	$2.750M	$2.800M	$2.700M	$2.550M	$2.370M	$2.260M	$2.540M
YoY Change	6.35%	-3.22%	2.6%	8.9%	3.41%	4.25%	0.2%	16.33%	24.44%	-2.4%	3.27%	-1.79%	3.7%	5.88%	7.59%	4.87%	-11.02%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Revenue	$4.984M	$4.687M	$4.842M	$4.720M	$4.334M	$4.191M	$4.020M	$4.012M	$3.449M	$2.772M	$2.840M	$2.750M	$2.800M	$2.700M	$2.550M	$2.370M	$2.260M	$2.540M
Cost Of Revenue	$1.093M	$1.117M	$1.357M	$1.331M	$1.135M	$1.142M	$1.085M	$1.263M	$1.030M	$808.5K	$710.0K	$700.0K	$700.0K	$600.0K	$540.0K	$450.0K	$450.0K	$600.0K
Gross Profit	$3.891M	$3.570M	$3.486M	$3.389M	$3.199M	$3.050M	$2.936M	$2.750M	$2.419M	$1.963M	$2.130M	$2.050M	$2.100M	$2.110M	$2.000M	$1.910M	$1.800M	$1.940M
Gross Profit Margin	78.07%	76.16%	71.98%	71.8%	73.82%	72.76%	73.02%	68.53%	70.12%	70.83%	75.0%	74.55%	75.0%	78.15%	78.43%	80.59%	79.65%	76.38%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operational Expenses

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Selling, General & Admin	$2.038M	$1.807M	$1.711M	$1.330M	$1.317M	$1.418M	$1.313M	$1.153M	$2.522M	$2.305M	$2.060M	$2.060M	$1.870M	$1.770M	$1.820M	$1.750M	$1.560M	$1.690M
YoY Change	12.78%	5.63%	28.6%	1.03%	-7.15%	8.04%	13.86%	-54.3%	9.45%	11.87%	0.0%	10.16%	5.65%	-2.75%	4.0%	12.18%	-7.69%
% of Gross Profit	52.37%	50.62%	49.07%	39.25%	41.15%	46.5%	44.71%	41.92%	104.28%	117.39%	96.71%	100.49%	89.05%	83.89%	91.0%	91.62%	86.67%	87.11%
Research & Development	$30.10K	$30.60K	$30.00K	$30.90K	$23.09K	$33.14K	$41.75K	$31.30K		$22.83K
YoY Change	-1.63%	2.0%	-2.91%	33.81%	-30.32%	-20.62%	33.39%
% of Gross Profit	0.77%	0.86%	0.86%	0.91%	0.72%	1.09%	1.42%	1.14%		1.16%
Depreciation & Amortization	$81.70K	$52.82K	$38.22K	$43.33K	$53.94K	$27.70K	$47.86K	$45.68K	$37.71K	$35.87K	$30.00K	$30.00K	$30.00K	$40.00K	$30.00K	$30.00K	$40.00K	$40.00K
YoY Change	54.69%	38.2%	-11.8%	-19.67%	94.72%	-42.12%	4.77%	21.14%	5.13%	19.57%	0.0%	0.0%	-25.0%	33.33%	0.0%	-25.0%	0.0%
% of Gross Profit	2.1%	1.48%	1.1%	1.28%	1.69%	0.91%	1.63%	1.66%	1.56%	1.83%	1.41%	1.46%	1.43%	1.9%	1.5%	1.57%	2.22%	2.06%
Operating Expenses	$2.068M	$1.838M	$1.741M	$1.361M	$1.340M	$1.451M	$1.354M	$1.184M	$2.522M	$22.83K	$2.060M	$2.060M	$1.870M	$1.770M	$1.830M	$1.750M	$1.560M	$1.690M
YoY Change	12.54%	5.57%	27.88%	1.59%	-7.68%	7.16%	14.37%	-53.05%	10950.43%	-98.89%	0.0%	10.16%	5.65%	-3.28%	4.57%	12.18%	-7.69%
Operating Profit	-$231.7K	-$97.38K	-$237.2K	$324.8K	$153.0K	$97.07K	$127.1K	$29.96K	-$103.6K	$1.940M	$70.00K	-$10.00K	$230.0K	$340.0K	$170.0K	$160.0K	$240.0K	$250.0K
YoY Change	137.94%	-58.95%	-173.04%	112.25%	57.63%	-23.62%	324.13%	-128.93%	-105.34%	2671.96%	-800.0%	-104.35%	-32.35%	100.0%	6.25%	-33.33%	-4.0%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Interest Expense	$24.64K	$11.82K	$0.00	$0.00	$0.00	$0.00	$0.00	$2.846K	$296.9K	$1.880K	$0.00	$0.00	-$10.00K	-$20.00K	-$30.00K	-$20.00K	-$30.00K	-$20.00K
YoY Change	108.46%						-100.0%	-99.04%	15694.15%			-100.0%	-50.0%	-33.33%	50.0%	-33.33%	50.0%
% of Operating Profit				0.0%	0.0%	0.0%	0.0%	9.5%		0.1%	0.0%		-4.35%	-5.88%	-17.65%	-12.5%	-12.5%	-8.0%
Other Income/Expense, Net	$60.42K	$32.01K	$1.804K	$507.1K	$7.049K	$2.240K	$556.00	-$978.00					$0.00	$0.00	$0.00		$0.00	$0.00
YoY Change	88.78%	1674.22%	-99.64%	7094.2%	214.69%	302.88%	-156.85%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Pretax Income	-$171.3K	-$65.37K	-$235.4K	$831.9K	$160.1K	$99.31K	$127.6K	$28.99K	$190.2K	-$339.5K	$70.00K	-$10.00K	$220.0K	$310.0K	$160.0K	$140.0K	$220.0K	$220.0K
YoY Change	162.0%	-72.23%	-128.3%	419.72%	61.17%	-22.19%	340.35%	-84.76%	-156.02%	-584.99%	-800.0%	-104.55%	-29.03%	93.75%	14.29%	-36.36%	0.0%
Income Tax	$169.9K	-$15.13K	-$25.62K	$64.31K	$48.41K	$72.09K	$383.4K	$16.61K	$80.60K	-$121.2K	$50.00K	$90.00K	$90.00K	$120.0K	$60.00K	$50.00K	-$640.0K	-$280.0K
% Of Pretax Income				7.73%	30.24%	72.59%	300.35%	57.3%	42.38%		71.43%		40.91%	38.71%	37.5%	35.71%	-290.91%	-127.27%
Net Earnings	-$341.1K	-$50.25K	-$209.8K	$767.6K	$111.7K	$83.64K	-$255.7K	$12.38K	$109.6K	-$218.3K	$20.00K	-$100.0K	$130.0K	$190.0K	$120.0K	$20.00K	$920.0K	$500.0K
YoY Change	578.95%	-76.05%	-127.33%	587.44%	33.5%	-132.71%	-2165.98%	-88.7%	-150.2%	-1191.35%	-120.0%	-176.92%	-31.58%	58.33%	500.0%	-97.83%	84.0%
Net Earnings / Revenue	-6.84%	-1.07%	-4.33%	16.26%	2.58%	2.0%	-6.36%	0.31%	3.18%	-7.87%	0.7%	-3.64%	4.64%	7.04%	4.71%	0.84%	40.71%	19.69%
Basic Earnings Per Share	-$0.04	-$0.01	-$0.03	$0.09	$0.01	$0.00	-$0.03	$0.00
Diluted Earnings Per Share	-$0.04	-$0.01	-$0.03	$0.09	$0.01	$0.00	-$0.03	$0.00	$13.27K	-$27.08K	$2.424K	-$12.41K	$15.76K	$23.03K	$14.55K	$2.418K	$109.1K	$59.81K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
Cash & Short-Term Investments	$908.8K	$1.014M	$1.042M	$1.507M	$821.0K	$444.2K	$423.8K	$275.3K	$211.2K	$361.9K	$740.0K	$930.0K	$1.060M	$880.0K	$880.0K	$650.0K	$520.0K	$420.0K
YoY Change	-10.35%	-2.66%	-30.89%	83.56%	84.8%	4.83%	53.92%	30.37%	-41.65%	-51.09%	-20.43%	-12.26%	20.45%	0.0%	35.38%	25.0%	23.81%
Cash & Equivalents
Short-Term Investments	$582.7K	$562.5K	$281.1K	$280.4K	$155.1K	$154.0K	$153.5K	$102.1K	$152.0K	$157.7K	$160.0K	$160.0K	$160.0K	$160.0K	$50.00K	$240.0K	$240.0K	$0.00
Other Short-Term Assets	$434.2K	$298.5K	$374.8K	$276.3K	$183.1K	$244.5K	$171.3K	$175.2K	$293.7K	$296.3K	$280.0K	$240.0K	$250.0K	$290.0K	$240.0K	$200.0K	$300.0K	$300.0K
YoY Change	45.46%	-20.37%	35.68%	50.84%	-25.09%	42.69%	-2.21%	-40.35%	-0.87%	5.83%	16.67%	-4.0%	-13.79%	20.83%	20.0%	-33.33%	0.0%
Inventory	$510.0K	$431.4K	$761.7K	$591.1K	$758.5K	$485.4K	$416.6K	$506.7K	$688.7K	$434.5K	$280.0K	$210.0K	$190.0K	$200.0K	$190.0K	$110.0K	$190.0K	$130.0K
Prepaid Expenses
Receivables	$512.9K	$494.0K	$407.1K	$497.4K	$311.0K	$419.6K	$372.3K	$391.5K	$538.2K	$260.1K	$300.0K	$190.0K	$210.0K	$310.0K	$180.0K	$220.0K	$170.0K	$220.0K
Other Receivables	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$150.0K	$0.00	$0.00	$0.00	$0.00	$10.00K	$0.00	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.366M	$2.238M	$2.585M	$2.872M	$2.074M	$1.594M	$1.384M	$1.349M	$1.882M	$1.353M	$1.600M	$1.580M	$1.730M	$1.690M	$1.490M	$1.180M	$1.180M	$1.080M
YoY Change	5.73%	-13.44%	-9.98%	38.48%	30.11%	15.16%	2.61%	-28.33%	39.11%	-15.45%	1.27%	-8.67%	2.37%	13.42%	26.27%	0.0%	9.26%
Property, Plant & Equipment	$600.2K	$808.2K	$859.9K	$991.6K	$483.1K	$488.5K	$512.4K	$513.8K	$540.6K	$496.9K	$470.0K	$490.0K	$510.0K	$540.0K	$510.0K	$540.0K	$560.0K	$590.0K
YoY Change	-25.74%	-6.01%	-13.29%	105.26%	-1.1%	-4.66%	-0.28%	-4.96%	8.8%	5.72%	-4.08%	-3.92%	-5.56%	5.88%	-5.56%	-3.57%	-5.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments							$0.00	$111.7K	$140.6K
YoY Change							-100.0%	-20.55%
Other Assets	$221.4K	$500.9K	$340.6K	$387.0K	$247.9K	$335.7K	$444.9K	$738.6K	$556.0K	$666.8K	$560.0K	$590.0K	$680.0K	$730.0K	$860.0K	$1.010M	$950.0K	$230.0K
YoY Change	-55.81%	47.07%	-11.98%	56.1%	-26.16%	-24.54%	-39.77%	32.84%	-16.61%	19.07%	-5.08%	-13.24%	-6.85%	-15.12%	-14.85%	6.32%	313.04%
Total Long-Term Assets	$838.5K	$1.326M	$1.217M	$1.396M	$748.0K	$841.1K	$974.2K	$1.381M	$1.237M	$1.164M	$1.030M	$1.080M	$1.190M	$1.260M	$1.380M	$1.540M	$1.500M	$820.0K
YoY Change	-36.77%	8.92%	-12.76%	86.58%	-11.07%	-13.66%	-29.46%	11.63%	6.32%	12.98%	-4.63%	-9.24%	-5.56%	-8.7%	-10.39%	2.67%	82.93%
Total Assets	$3.204M	$3.564M	$3.803M	$4.267M	$2.822M	$2.435M	$2.358M	$2.730M	$3.119M	$2.516M	$2.630M	$2.660M	$2.920M	$2.950M	$2.870M	$2.720M	$2.680M	$1.900M
YoY Change
Accounts Payable	$160.9K	$175.1K	$178.1K	$167.6K	$167.5K	$147.5K	$95.47K	$120.6K	$358.2K	$121.4K	$110.0K	$140.0K	$150.0K	$130.0K	$180.0K	$140.0K	$110.0K	$110.0K
YoY Change	-8.08%	-1.7%	6.26%	0.08%	13.57%	54.45%	-20.82%	-66.34%	195.14%	10.33%	-21.43%	-6.67%	15.38%	-27.78%	28.57%	27.27%	0.0%
Accrued Expenses	$608.3K	$451.1K	$465.2K	$568.0K	$289.5K	$228.5K	$228.9K	$315.8K	$355.7K	$159.4K	$140.0K	$170.0K	$200.0K	$150.0K	$130.0K	$130.0K	$120.0K	$110.0K
YoY Change	34.86%	-3.03%	-18.11%	96.22%	26.69%	-0.17%	-27.53%	-11.22%	123.17%	13.86%	-17.65%	-15.0%	33.33%	15.38%	0.0%	8.33%	9.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$125.0K	$80.00K	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
YoY Change								-100.0%	56.25%
Long-Term Debt Due					$57.03K	$0.00	$2.110K	$3.790K	$3.790K			$0.00	$50.00K	$30.00K	$30.00K	$20.00K	$20.00K	$20.00K
YoY Change						-100.0%	-44.33%	0.0%				-100.0%	66.67%	0.0%	50.0%	0.0%	0.0%
Total Short-Term Liabilities	$769.2K	$626.1K	$643.2K	$735.6K	$514.0K	$375.9K	$326.5K	$440.2K	$842.7K	$360.8K	$250.0K	$310.0K	$400.0K	$310.0K	$340.0K	$290.0K	$250.0K	$240.0K
YoY Change	22.86%	-2.66%	-12.56%	43.12%	36.71%	15.15%	-25.83%	-47.76%	133.59%	44.3%	-19.35%	-22.5%	29.03%	-8.82%	17.24%	16.0%	4.17%
Long-Term Debt	$0.00	$0.00	$0.00	$0.00	$144.0K	$0.00	$0.00	$2.110K	$5.900K	$0.00	$0.00	$0.00	$60.00K	$310.0K	$400.0K	$420.0K	$450.0K	$470.0K
YoY Change				-100.0%			-100.0%	-64.24%				-100.0%	-80.65%	-22.5%	-4.76%	-6.67%	-4.26%
Other Long-Term Liabilities	$139.2K	$319.9K	$491.3K	$653.9K
YoY Change	-56.48%	-34.89%	-24.86%
Total Long-Term Liabilities	$139.2K	$319.9K	$491.3K	$653.9K	$144.0K	$0.00	$0.00	$2.110K	$5.900K	$0.00	$0.00	$0.00	$60.00K	$310.0K	$400.0K	$420.0K	$450.0K	$470.0K
YoY Change	-56.48%	-34.89%	-24.86%	354.16%			-100.0%	-64.24%				-100.0%	-80.65%	-22.5%	-4.76%	-6.67%	-4.26%
Total Liabilities	$917.1K	$946.0K	$1.135M	$1.389M	$657.9K	$375.9K	$326.5K	$442.3K	$848.6K	$360.8K	$250.0K	$310.0K	$460.0K	$620.0K	$740.0K	$710.0K	$690.0K	$710.0K
YoY Change	-3.05%	-16.62%	-18.35%	111.19%	75.01%	15.15%	-26.19%	-47.88%	135.23%	44.3%	-19.35%	-32.61%	-25.81%	-16.22%	4.23%	2.9%	-2.82%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

Treasury Stock Shares

Stock Issuance & Repurchase

Ownership Data

Concept	2024	2023	2022	2021	2020	2019	2018	2017
Basic Shares Outstanding	8.120M	8.087M	8.087M	8.087M	8.087M	8.087M	8.077M	8.063M
Diluted Shares Outstanding	8.120M	8.087M	8.087M	8.320M	8.319M	8.319M	8.077M	8.280M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Stock Price

Market Cap: $1.6321 Million

About PROCYON CORP

Procyon Corp. is a holding company, which engages in the development and marketing of proprietary medical products. The company is headquartered in Clearwater, Florida and currently employs 19 full-time employees. AMERX develops and markets medical products used in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation and other skin problems. Its product lines include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, EXTREMIT-EASE Compression Garment and Advantagen Surgical Collagen. AMERX markets a proprietary line of AMERIGEL advanced skin and wound care products made with Oakin, that promote healing in wound and problematic skin conditions, including AMERIGEL Hydrogel Wound Dressing, AMERIGEL Post Op Surgical Kits, AMERIGEL Saline Wound Wash, AMERIGEL Care Lotion, and AMERIGEL Barrier Lotion. HELIX3 is available in Collagen Powder (HELIX3 CP) and Collagen Matrix (HELIX3 CM). Its wound care product includes AMERX Calcium Alginate Dressing, AMERX Foam Dressing, AMERX Gauze Dressing, AMERX Hyrdocolloid Dressing, and AMERX Wound Care Kits.

Industry: Pharmaceutical Preparations Peers: E Med Future, Inc. Arch Therapeutics, Inc. CHEMBIO DIAGNOSTICS, INC. Rapid Therapeutic Science Laboratories, Inc. VYCOR MEDICAL INC